VJHemOnc Podcast iwAL 2023 Session IV: Transplantation and immunotherapies in AML: improving patient outcomes
Oct 20, 2023
Charles Craddock and David Sallman discuss transplantation and immunotherapies in AML, focusing on patient eligibility, challenges in CAR-T therapy, targeting pre-transplant minimal residual disease, and improving patient outcomes through DLI and gamma delta T cells. They also explore the design of a randomized study evaluating prophylactic DLI in high-risk AML patients.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 3min
Patient Eligibility and Challenges in Transplantation and Immunotherapies for AML
02:53 • 3min
Targeting Pre-Transplant MRT for Improved AML Patient Outcomes
05:35 • 2min
Improving Patient Outcomes Through Transplantation and Immunotherapies
07:49 • 4min
Designing a Randomized Study and Lessons from Morpho Data in Transplantation and Immunotherapies for AML
11:53 • 3min